December 20, 2022

The November/December 2022 News from ECOG-ACRIN blog is now available

October 26, 2022

Press Release: NCI-MATCH cancer trial finds a promising signal for the AKT inhibitor ipatasertib

October 20, 2022

Press Release: ECOG-ACRIN taps the University of Pennsylvaniaโ€™s Selina Luger to lead its Leukemia Committee

October 13, 2022

The September/October 2022 News from ECOG-ACRIN blog is now available

August 16, 2022

The August 2022 News from ECOG-ACRIN blog is now available

June 22, 2022

FDA approves dabrafenib plus trametinib for BRAF V600E-mutated tumors based on data from NCI-MATCH

June 1, 2022

Precision medicine clinical trials: A conversation between Peter Oโ€™Dwyer and Lale Kostakoglu

May 27, 2022

Press Release: ECOG-ACRIN research highlights at ASCO 2022

May 17, 2022

Media Advisory: ECOG-ACRIN data at ASCO will showcase the Groupโ€™s robust research portfolio

ECOG-ACRIN Cancer Research Group